The work is being carried out as part of its pavement category management framework agreement with National Highways.
Hanson says this is the first time it has trialled the CarbonLock asphalt containing polymer modified bitumen (PMB) bio-binders on the strategic road network in partnership with National Highways.
Two trials are being carried out. The first trial includes Nynas’s biogenic binder Nypol RE and the second trial uses the same asphalt mixture but includes Shell’s new bio-component binder Cariphalte CarbonSink.
Both asphalts were produced at Hanson’s Hingston Down plant and laid by Hanson Contracting. Each trial comprised a 40mm thickness surface course with 53 PSV aggregates for around 500 metres of both lanes of the eastbound carriageway.
Natural biogenic material absorbs and stores CO2, which is then ‘locked’ into the bio-component binders (bio-binders) and not released back into the atmosphere, even when the asphalt is recycled. In addition, the PMB binder used in both trials is expected to enhance durability and further extend the life of the asphalt, thus reducing the frequency of maintenance interventions.
Adrian Hadley, technical head (asphalt and aggregate) at Hanson UK, said: “We are committed to working with our clients to help them meet their net zero objectives and these trials are an excellent example of this.”
The work was coordinated by Atkins as part of the National Highways research project Future Asphalt Surface Course Linking to NH Net Zero under SPaTS 2. The performance of the two trial sections will be closely monitored to see how they compare with ‘standard’ PMB asphalt used elsewhere on the project.
Umesh Parajuli of the pavements team in the safety engineering and standards division, National Highways, said: “These trials are part of our feasibility study and whole-life benefits analysis of emerging low carbon technologies, which will help us meet our 2040 net zero carbon deadline for construction and maintenance activities.”